Previous studies in NB identified DCX mRNA encoding the core component of neuronal motility, as a robust minimal residual disease marker associated with poor survival in NB patients (Hartomo et al, 2013; Viprey et al, 2014). This evidence concerns the gene DCX and neuroblastoma.